For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

The annual meeting of the American College of Physicians (Internal Medicine Meeting) was held from April 3 to 5 in New ...

New research shows that people who take the weight-loss drug tirzepatide can keep most of the weight off for at least three ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Guggenheim lowered the firm’s price target on Eli Lilly (LLY) to $928 from $973 and keeps a Buy rating on the shares. The firm is updating its ...

Rebecca Banks, from Lancashire, had tried Saxenda jabs, Weight Watchers and fasting, but nothing seemed to work.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in ...

A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The results showed that weight loss was significant and mostly came from fat, not muscle. On average, women lost about 12% of ...